Published in Apoptosis on July 01, 2004
Structural genomics analysis of alternative splicing and application to isoform structure modeling. Proc Natl Acad Sci U S A (2005) 1.15
Death receptor-associated pro-apoptotic signaling in aged skeletal muscle. Apoptosis (2006) 1.05
Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2. Br J Cancer (2009) 1.03
Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life. Hum Gene Ther (2005) 1.01
Novel intestinal splice variants of RNA-binding protein CUGBP2: isoform-specific effects on mitotic catastrophe. Am J Physiol Gastrointest Liver Physiol (2008) 0.90
Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3. Oncotarget (2016) 0.89
Modulation of apoptosis in human hepatocellular carcinoma (HepG2 cells) by a standardized herbal decoction of Nigella sativa seeds, Hemidesmus indicus roots and Smilax glabra rhizomes with anti- hepatocarcinogenic effects. BMC Complement Altern Med (2012) 0.85
Activation of apoptosis by 1-hydroxy-5,7-dimethoxy-2-naphthalene-carboxaldehyde, a novel compound from Aegle marmelos. Cancer Res (2008) 0.85
Transportin 2 regulates apoptosis through the RNA-binding protein HuR. J Biol Chem (2011) 0.84
Cardiorenal Syndrome Type 1 May Be Immunologically Mediated: A Pilot Evaluation of Monocyte Apoptosis. Cardiorenal Med (2012) 0.84
Epithelial membrane protein 1 negatively regulates cell growth and metastasis in colorectal carcinoma. World J Gastroenterol (2014) 0.83
Ion channel inhibitors block caspase activation by mechanisms other than restoring intracellular potassium concentration. Cell Death Dis (2011) 0.82
Evidence for programmed cell death and activation of specific caspase-like enzymes in the tomato fruit heat stress response. Planta (2009) 0.81
Functional evaluation of a fluorescent schweinfurthin: mechanism of cytotoxicity and intracellular quantification. Mol Pharmacol (2012) 0.81
Possible contribution of beta-glycosidases and caspases in the cytotoxicity of novel glycoconjugates in colon cancer cells. Invest New Drugs (2009) 0.78
Altered of apoptotic markers of both extrinsic and intrinsic pathways induced by hepatitis C virus infection in peripheral blood mononuclear cells. Virol J (2012) 0.77
Emetine regulates the alternative splicing of caspase 9 in tumor cells. Oncol Lett (2011) 0.77
Caspase-9: structure, mechanisms and clinical application. Oncotarget (2017) 0.75
[Not Available]. J Oncol (2009) 0.75
Protective effect of DHEA on hydrogen peroxide-induced oxidative damage and apoptosis in primary rat Leydig cells. Oncotarget (2017) 0.75
Anti-hepatocarcinogenic and Anti-oxidant Effects of Mangrove Plant Scyphiphora hydrophyllacea. Pharmacogn Mag (2017) 0.75
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature (1996) 6.75
Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7 alpha-hydroxylase. Am J Physiol (1996) 1.45
Differential regulation of the mitogen-activated protein and stress-activated protein kinase cascades by adrenergic agonists in quiescent and regenerating adult rat hepatocytes. Mol Cell Biol (1997) 1.17
Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA. Cancer Res (1992) 1.08
Role of sphingolipid-mediated cell death in neurodegenerative diseases. J Lipid Res (1998) 1.03
Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to a sublethal concentration of doxorubicin. Cell Growth Differ (1994) 0.97
Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro. Endocrinology (1996) 0.90
Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine. Endocrinology (1988) 0.87
Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67). Cell Growth Differ (1996) 0.83
Follicular dendritic cells protect malignant B cells from apoptosis induced by anti-Fas and antineoplastic agents. J Immunol (1999) 0.83
Downregulation of delta CaM kinase II in human tumor cells. Biochim Biophys Acta (1999) 0.82
Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2. Mol Pharmacol (1997) 0.78
Induction of interleukin-6 release by interleukin-1 in rat anterior pituitary cells in vitro: evidence for an eicosanoid-dependent mechanism. Endocrinology (1991) 0.78
Modulation of drug-induced apoptosis by interruption of the protein kinase C signal transduction pathway: a new therapeutic strategy. Clin Cancer Res (1996) 0.77
Requirement for SAPK-JNK signaling in the induction of apoptosis by ribosomal stress in REH lymphoid leukemia cells. Leukemia (2003) 0.77
Cost control in the hospital lab. Dimens Health Serv (1974) 0.77
Induction of apoptotic DNA fragmentation and c-jun downregulation in human myeloid leukemia cells by the permeant Ca2+ chelator BAPTA/AM. Oncol Res (1995) 0.77
Dopamine does not attenuate phosphoinositide hydrolysis in rat anterior pituitary cells. J Endocrinol (1986) 0.77
Potentiation of ara-C-induced apoptosis by the protein kinase C activator bryostatin 1 in human leukemia cells (HL-60) involves a process dependent upon c-Myc. Biochem Pharmacol (1997) 0.76
Calcitonin decreases thyrotropin-releasing hormone-stimulated prolactin release through a mechanism that involves inhibition of inositol phosphate production. Endocrinology (1990) 0.76
Effect of AS101 on bryostatin 1-mediated differentiation induction, cell cycle arrest, and modulation of drug-induced apoptosis in human myeloid leukemia cells. Leukemia (1996) 0.75
Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis. Exp Cell Res (1996) 0.75
Radiosensitization of HL-60 human leukaemia cells by bryostatin-1 in the absence of increased DNA fragmentation or apoptotic cell death. Int J Radiat Biol (1996) 0.75
Effects of bryostatin 1 and calcium ionophore (A23187) on apoptosis and differentiation in human myeloid leukemia cells (HL-60) following 1-beta-D-arabinofuranosylcytosine exposure. Int J Oncol (1998) 0.75
Thymosin fraction 5 stimulates prolactin and growth hormone release from anterior pituitary cells in vitro. Endocrinology (1987) 0.75
Attenuation of pituitary polyphosphoinositide metabolism by protein kinase C activation. Mol Cell Endocrinol (1987) 0.75
Effects of bryostatin 1 and rGM-CSF on the metabolism of 1-beta-D-arabinofuranosylcytosine in human leukaemic myeloblasts. Br J Haematol (1992) 0.75
Modulation of the expression of Bcl-2 and related proteins in human leukemia cells by protein kinase C activators: relationship to effects on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis. Cell Death Differ (1997) 0.75
Impaired calcium mobilisation in the 7315a prolactin-secreting pituitary tumour. Cell Calcium (1987) 0.75
Non-pituitary actions of hypothalamic hormones. Functional significance and therapeutic implications. General introduction. Acta Endocrinol Suppl (Copenh) (1986) 0.75
Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C. Oncol Res (1994) 0.75
Physiological and biochemical effects of bradykinin and lys-bradykinin in pituitary cells. Mol Cell Endocrinol (1990) 0.75
Cholinergic stimulation of inositol phosphate production in cultured anterior pituitary cells. Neuroendocrinology (1987) 0.75
Prolactin secretion by human chorion-decidua in vitro: influences of mode of delivery and agents that modify prostaglandin synthesis. Am J Obstet Gynecol (1983) 0.75